Bayer and DiaSys Renew Strategic Cooperation Agreement in Canada.TORONTO--(BUSINESS WIRE)--June 30, 1999-- DiaSys Corporation (NASD NASD See: National Association of Securities Dealers NASD See National Association of Securities Dealers (NASD). :DIYS) today announced that it has renewed its strategic cooperation agreement with the Health Care Division of Bayer Incorporated, the Canadian subsidiary of the international chemical and health care giant, Bayer AG Bayer AG German chemical and pharmaceutical company. Founded in 1863 by Friedrich Bayer (1825–1880), it now operates plants in more than 30 countries. Bayer has originated scores of pharmaceuticals, chemicals, and synthetic materials; it was the first developer and (Germany). Under the Agreement, Bayer and DiaSys jointly market their urinalysis instrumentation to hospital and clinical reference laboratories throughout Canada. DiaSys has a similar strategic relationship with the Diagnostic Division of Bayer Corporation in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . Bayer Incorporated, with headquarters in Toronto, Canada, is a member of the worldwide Bayer Group, a multi-billion dollar chemical and pharmaceutical company based in Leverkusen, Germany. DiaSys Corporation designs, develops, manufactures and distributes workstation-products which standardize and reduce the cost for analyzing urine sediment and fecal concentrates. DiaSys is a registered trademark of DiaSys Corporation. The foregoing press release includes "forward looking statements" within the meaning of and made pursuant to the safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. DiaSys refers interested parties to its most recent Annual Report on form 10-KSB and other SEC filings for a complete description of and discussion about the Company. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion